Main Category: Prostate / Prostate Cancer
Also Included In: Genetics
Article Date: 21 Mar 2013 – 0:00 PDT
email to a friend printer friendly opinions
<!– rate article
Patient / Public:Healthcare Prof:
Patients with benign prostatic hyperplasia (BPH) carrying prostate cancer (PCa) a risk alleles are a potential target population for PCa screening and follow-up, according to a study, which was presented at the 28th Annual EAU Congress in Milan.
The study aimed to evaluate the genetic predisposition of patients with BPH to developing prostate cancer, with findings suggesting that genetic testing may offer a new tool to identify BPH patients with increased risk to develop PrCa.
“To our knowledge this is the first study to evaluate genetic predisposition in BPH patients developing PrCa,” write the authors.
Benign prostatic hyperplasia and prostate cancer are common diseases affecting the prostate gland in aging men. Although BPH often explains the increase of PSA, the patients with elevated PSA often develop prostate cancer in follow-up after initial benign histology in prostate biopsy.
The researchers were looking to find new potential tools which would help to identify patients with elevated PCa risk among those who undergo biopsy due to rCa suspicion but have histologically confirmed BPH and no PCa in baseline biopsy.
Read more at: http://www.medicalnewstoday.com/releases/257908.php